OPKO Health Shares Outstanding 2010-2025 | OPK
OPKO Health shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| OPKO Health Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 694 |
| 2023 | 752 |
| 2022 | 719 |
| 2021 | 648 |
| 2020 | 641 |
| 2019 | 595 |
| 2018 | 563 |
| 2017 | 559 |
| 2016 | 556 |
| 2015 | 488 |
| 2014 | 422 |
| 2013 | 355 |
| 2012 | 296 |
| 2011 | 281 |
| 2010 | 255 |
| 2009 | 233 |
| OPKO Health Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 672 |
| 2024-12-31 | 694 |
| 2024-09-30 | 998 |
| 2024-06-30 | 697 |
| 2024-03-31 | 707 |
| 2023-12-31 | 752 |
| 2023-09-30 | 752 |
| 2023-06-30 | 752 |
| 2023-03-31 | 752 |
| 2022-12-31 | 719 |
| 2022-09-30 | 750 |
| 2022-06-30 | 713 |
| 2022-03-31 | 660 |
| 2021-12-31 | 648 |
| 2021-09-30 | 652 |
| 2021-06-30 | 647 |
| 2021-03-31 | 641 |
| 2020-12-31 | 641 |
| 2020-09-30 | 641 |
| 2020-06-30 | 641 |
| 2020-03-31 | 641 |
| 2019-12-31 | 595 |
| 2019-09-30 | 586 |
| 2019-06-30 | 586 |
| 2019-03-31 | 586 |
| 2018-12-31 | 563 |
| 2018-09-30 | 560 |
| 2018-06-30 | 560 |
| 2018-03-31 | 559 |
| 2017-12-31 | 559 |
| 2017-09-30 | 559 |
| 2017-06-30 | 564 |
| 2017-03-31 | 558 |
| 2016-12-31 | 556 |
| 2016-09-30 | 552 |
| 2016-06-30 | 557 |
| 2016-03-31 | 546 |
| 2015-12-31 | 488 |
| 2015-09-30 | 516 |
| 2015-06-30 | 462 |
| 2015-03-31 | 446 |
| 2014-12-31 | 422 |
| 2014-09-30 | 428 |
| 2014-06-30 | 413 |
| 2014-03-31 | 413 |
| 2013-12-31 | 355 |
| 2013-09-30 | 361 |
| 2013-06-30 | 337 |
| 2013-03-31 | 313 |
| 2012-12-31 | 296 |
| 2012-09-30 | 298 |
| 2012-06-30 | 298 |
| 2012-03-31 | 298 |
| 2011-12-31 | 281 |
| 2011-09-30 | 286 |
| 2011-06-30 | 285 |
| 2011-03-31 | 261 |
| 2010-12-31 | 255 |
| 2010-09-30 | 255 |
| 2010-06-30 | 255 |
| 2010-03-31 | 254 |
| 2009-12-31 | 233 |
| 2009-09-30 | 253 |
| 2009-06-30 | 226 |
| 2009-03-31 | 200 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.047B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $191.463B | 83.86 |
| Thermo Fisher Scientific (TMO) | United States | $155.573B | 18.82 |
| Edwards Lifesciences (EW) | United States | $45.256B | 29.67 |
| Alcon (ALC) | Switzerland | $42.967B | 29.04 |
| IDEXX Laboratories (IDXX) | United States | $42.445B | 48.78 |
| DexCom (DXCM) | United States | $33.345B | 51.54 |
| IQVIA Holdings (IQV) | United States | $27.362B | 15.33 |
| Mettler-Toledo (MTD) | United States | $24.800B | 29.49 |
| STERIS (STE) | Ireland | $23.464B | 25.84 |
| Waters (WAT) | United States | $21.120B | 29.80 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.882B | 0.00 |
| Hologic (HOLX) | United States | $14.509B | 15.77 |
| Sysmex ADR (SSMXY) | Japan | $10.777B | 30.57 |
| Penumbra (PEN) | United States | $9.820B | 77.08 |
| Masimo (MASI) | United States | $9.039B | 33.34 |
| Globus Medical (GMED) | United States | $7.963B | 18.97 |
| Glaukos (GKOS) | United States | $5.775B | 0.00 |
| Teleflex (TFX) | United States | $5.284B | 8.72 |
| TransMedics (TMDX) | United States | $4.399B | 95.63 |
| Integer Holdings (ITGR) | United States | $4.252B | 22.28 |
| PROCEPT BioRobotics (PRCT) | United States | $3.244B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.497B | 14.87 |
| Veracyte (VCYT) | United States | $2.100B | 29.46 |
| Nihon Kohden (NHNKY) | Japan | $2.016B | 23.12 |
| Elekta AB (EKTAY) | Sweden | $1.956B | 17.59 |
| Alphatec Holdings (ATEC) | United States | $1.593B | 0.00 |
| Artivion (AORT) | United States | $1.308B | 122.48 |
| Tandem Diabetes Care (TNDM) | United States | $1.273B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.002B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.949B | 5.05 |
| IRadimed (IRMD) | United States | $0.772B | 39.17 |
| SiBone (SIBN) | United States | $0.771B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.650B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.563B | 8.76 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.529B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.526B | 12.32 |
| Delcath Systems (DCTH) | United States | $0.489B | 0.00 |
| AxoGen (AXGN) | United States | $0.477B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.433B | 11.51 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.401B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.387B | 0.00 |
| NeuroPace (NPCE) | United States | $0.359B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.352B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.336B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.256B | 0.00 |
| 908 Devices (MASS) | United States | $0.242B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.238B | 14.42 |
| Biosig Technologies (BSGM) | United States | $0.232B | 0.00 |
| Neuronetics (STIM) | United States | $0.224B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.193B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| Accuray (ARAY) | United States | $0.136B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.113B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.20 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.06 |